| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.980 | 50 | 0 | 1999 | 2020 | ||||||||
|
MCF.2 cell line derived transforming sequence like | 0.559 | 0.769 | 2.7E-07 |
|
disease | 0.100 | None | 0.979 | 47 | 1 | 2010 | 2019 | ||||||||
|
LDL receptor related protein 2 | 0.491 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.979 | 47 | 0 | 2010 | 2019 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.977 | 43 | 0 | 2006 | 2020 | ||||||||
|
synuclein alpha interacting protein | 0.691 | 0.423 | 3.3E-04 |
|
disease | 0.100 | None | 1.000 | 42 | 4 | 2000 | 2019 | ||||||||
|
eukaryotic translation elongation factor 1 alpha 2 | 0.554 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.974 | 39 | 0 | 2004 | 2020 | ||||||||
|
CHM Rab escort protein | 0.592 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0.892 | 37 | 1 | 2000 | 2020 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.400 | None | 0.971 | 35 | 3 | 1993 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.100 | None | 0.970 | 33 | 0 | 2016 | 2020 | ||||||||
|
GTP cyclohydrolase 1 | 0.511 | 0.846 | 0.90 |
|
disease | 0.200 | None | 1.000 | 33 | 3 | 1996 | 2019 | ||||||||
|
HtrA serine peptidase 2 | 0.542 | 0.692 | 3.6E-03 |
|
disease | 0.100 | None | 0.969 | 32 | 4 | 2005 | 2018 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.300 | None | 0.875 | 32 | 2 | 2002 | 2020 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 0.968 | 31 | 0 | 2017 | 2020 | ||||||||
|
citron rho-interacting serine/threonine kinase | 0.555 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 29 | 1 | 1998 | 2019 | ||||||||
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.600 | None | 0.966 | 29 | 1 | 1996 | 2020 | ||||||||
|
dopa decarboxylase | 0.535 | 0.769 | 3.8E-08 |
|
disease | 0.600 | None | 1.000 | 28 | 0 | 1988 | 2019 | ||||||||
|
neurturin | 0.686 | 0.538 | 3.0E-02 |
|
disease | 0.100 | None | 0.964 | 28 | 0 | 2007 | 2020 | ||||||||
|
paired like homeodomain 3 | 0.585 | 0.692 | 0.81 |
|
disease | 0.300 | None | 0.893 | 28 | 4 | 2001 | 2020 | ||||||||
|
Parkinson disease 16 (susceptibility) | 0.861 | 0.077 |
|
disease | 0.400 | None | 0.963 | 27 | 0 | 2009 | 2019 | |||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.100 | None | 0.963 | 27 | 2 | 2004 | 2019 | ||||||||
|
M-phase phosphoprotein 6 | 0.729 | 0.308 | 4.1E-04 |
|
disease | 0.100 | None | 1.000 | 26 | 1 | 2000 | 2019 | ||||||||
|
glucosylceramidase beta pseudogene 1 | 0.623 | 0.538 |
|
disease | 0.100 | None | 1.000 | 26 | 1 | 2005 | 2019 | |||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2000 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2005 | 2020 |